BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33549705)

  • 21. Presurgical axitinib therapy increases fibrotic reactions within tumor thrombus in renal cell carcinoma with thrombus extending to the inferior vena cava.
    Tanaka Y; Hatakeyama S; Hosogoe S; Tanaka T; Hamano I; Kusaka A; Iwamura H; Fujita N; Yamamoto H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Ohyama C
    Int J Clin Oncol; 2018 Feb; 23(1):134-141. PubMed ID: 28752352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. En bloc retroperitoneal laparoscopic radical nephrectomy with inferior vena cava thrombectomy for renal cell carcinoma with level 0 to II venous tumor thrombus: A single-center experience.
    Tian X; Hong P; Liu Z; Huang Y; Wang G; Hou X; Zhang S; Ma L
    Cancer; 2020 May; 126 Suppl 9():2073-2078. PubMed ID: 32293727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Body mass index as an independent risk factor for inferior vena cava resection during thrombectomy for venous tumor thrombus of renal cell carcinoma.
    Wang BS; Ma RZ; Liu YQ; Liu Z; Tao LY; Lu M; Wang GL; Zhang SD; Lu J; Ma LL
    World J Surg Oncol; 2019 Jan; 17(1):17. PubMed ID: 30646899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus.
    Kaplan S; Ekici S; Doğan R; Demircin M; Ozen H; Paşaoğlu I
    Am J Surg; 2002 Mar; 183(3):292-9. PubMed ID: 11943130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereotactic Ablative Radiation Therapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer.
    Zhang Y; Schoenhals J; Christie A; Mohamad O; Wang C; Bowman I; Singla N; Hammers H; Courtney K; Bagrodia A; Margulis V; Desai N; Garant A; Choy H; Timmerman R; Brugarolas J; Hannan R
    Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):367-375. PubMed ID: 31377159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bland thrombus association with tumour thrombus in renal cell carcinoma: analysis of surgical significance and role of inferior vena caval interruption.
    Ayyathurai R; Garcia-Roig M; Gorin MA; González J; Manoharan M; Kava BR; Soloway MS; Ciancio G
    BJU Int; 2012 Dec; 110(11 Pt B):E449-55. PubMed ID: 22540981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical strategy for treating renal cell carcinoma with thrombus extending into the inferior vena cava.
    Jibiki M; Iwai T; Inoue Y; Sugano N; Kihara K; Hyochi N; Sunamori M
    J Vasc Surg; 2004 Apr; 39(4):829-35. PubMed ID: 15071451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative metastatic status, level of thrombus and body mass index predict overall survival in patients undergoing nephrectomy and inferior vena cava thrombectomy.
    Spiess PE; Kurian T; Lin HY; Rawal B; Kim T; Sexton WJ; Pow-Sang JM
    BJU Int; 2012 Dec; 110(11 Pt B):E470-4. PubMed ID: 22519938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective phase I dose-escalation trial of stereotactic ablative radiotherapy (SABR) as an alternative to cytoreductive nephrectomy for inoperable patients with metastatic renal cell carcinoma.
    Correa RJM; Ahmad B; Warner A; Johnson C; MacKenzie MJ; Pautler SE; Bauman GS; Rodrigues GB; Louie AV
    Radiat Oncol; 2018 Mar; 13(1):47. PubMed ID: 29558966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transabdominal two-cavity approach for radical nephrectomy combined with inferior vena cava thrombectomy for malignant thrombus caused by renal cell carcinoma: a case series.
    Novotny R; Chlupac J; Marada T; Borovicka V; Vik V; Voska L; Janousek L; Fronek J
    J Med Case Rep; 2018 Oct; 12(1):313. PubMed ID: 30355283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
    Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcome of surgical management for patients with renal cell carcinoma involving the inferior vena cava.
    Terakawa T; Miyake H; Takenaka A; Hara I; Fujisawa M
    Int J Urol; 2007 Sep; 14(9):781-4. PubMed ID: 17760741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary tumor embolization as early manifestation in patients with renal cell carcinoma and tumor thrombus: Perioperative management and outcomes.
    Serena G; Gonzalez J; Gaynor JJ; Salerno T; Verzaro R; Ciancio G
    J Card Surg; 2019 Oct; 34(10):1018-1023. PubMed ID: 31376225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transitional cell carcinoma with extension of the renal vein and IVC tumor thrombus: report of three cases and literature review.
    Li M; Shi A; Kong W; Zhang J; Chen Y; Huang J; Huang Y
    World J Surg Oncol; 2016 Dec; 14(1):309. PubMed ID: 28031042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of venous thrombus in renal cell carcinoma. Are renal vein and inferior vena cava involvement different?
    Kim HL; Zisman A; Han KR; Figlin RA; Belldegrun AS
    J Urol; 2004 Feb; 171(2 Pt 1):588-91. PubMed ID: 14713765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases.
    Wang CJ; Christie A; Lin MH; Jung M; Weix D; Huelsmann L; Kuhn K; Meyer J; Desai N; Kim DWN; Pedrosa I; Margulis V; Cadeddu J; Sagalowsky A; Gahan J; Laine A; Xie XJ; Choy H; Brugarolas J; Timmerman R; Hannan R
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):91-100. PubMed ID: 28587057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial.
    Siva S; Bressel M; Sidhom M; Sridharan S; Vanneste BGL; Davey R; Montgomery R; Ruben J; Foroudi F; Higgs B; Lin C; Raman A; Hardcastle N; Hofman MS; De Abreu Lourenco R; Shaw M; Mancuso P; Moon D; Wong LM; Lawrentschuk N; Wood S; Brook NR; Kron T; Martin J; Pryor D;
    Lancet Oncol; 2024 Mar; 25(3):308-316. PubMed ID: 38423047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney).
    Siva S; Ali M; Correa RJM; Muacevic A; Ponsky L; Ellis RJ; Lo SS; Onishi H; Swaminath A; McLaughlin M; Morgan SC; Cury FL; Teh BS; Mahadevan A; Kaplan ID; Chu W; Grubb W; Hannan R; Staehler M; Warner A; Louie AV
    Lancet Oncol; 2022 Dec; 23(12):1508-1516. PubMed ID: 36400098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inferior Vena Cava Reconstruction Using a Ringed Polytetrafluoroethylene Interposition Graft and Inferior Vena Cava Filter Placement Following Resection of Renal Cell Carcinoma With a Tumor Thrombus Directly Infiltrating the Inferior Vena Cava.
    Ciancio G
    Vasc Endovascular Surg; 2022 Jan; 56(1):5-10. PubMed ID: 34372714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncological outcomes after cytoreductive nephrectomy for patients with metastatic renal cell carcinoma with inferior vena caval tumor thrombus.
    Miyake H; Sugiyama T; Aki R; Matsushita Y; Tamura K; Motoyama D; Ito T; Otsuka A
    Int J Clin Oncol; 2018 Jun; 23(3):553-558. PubMed ID: 29332206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.